Vanguard Esg Developed Europe All Cap Ucits Etf Eur Distribut News - V3DL

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 02, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics...

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

The AlterG NEO combines updated user-friendly design with trusted Anti-Gravity technology for precise and...

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics...

Lifeward Reports First Quarter 2024 Financial Results

Q1’24 revenue of $5.3M is up 340% vs. Q1’23 and at the midpoint of Lifeward’s guidance range Newly established...

Lifeward to Report First Quarter Financial Results on May 15, 2024

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA...

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 19, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics...

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA...

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

Collaboration with CMS on final payment rate focuses on commercial transaction values for the latest generation...

VA STAND Act introduced in the United States Senate

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics...

Lifeward Announces Reverse Share Split

Reverse split initiated to regain compliance with Nasdaq listing requirements Financial guidance for 2024 and...

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving...

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b

The decision was communicated through CMS’ bi-annual Healthcare Common Procedure Coding System (“HCPCS”) coding...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Vanguard Esg Developed Europe All Cap Ucits Etf Eur Distribut (V3DL)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

V3DL News

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

Lifeward Reports First Quarter 2024 Financial Results

Lifeward to Report First Quarter Financial Results on May 15, 2024

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

VA STAND Act introduced in the United States Senate

Lifeward Announces Reverse Share Split

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

V3DL Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Vanguard Esg Developed Europe All Cap Ucits Etf Eur Distribut (V3DL) News

Vanguard Esg Developed Europe All Cap Ucits Etf Eur Distribut (V3DL)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

V3DL News

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

Lifeward Reports First Quarter 2024 Financial Results

Lifeward to Report First Quarter Financial Results on May 15, 2024

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

VA STAND Act introduced in the United States Senate

Lifeward Announces Reverse Share Split

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

V3DL Discussion

Your Recent History